Recombinant anti-CD40 monoclonal antibody

Recombinant anti-CD40 monoclonal antibody
Trade Name
Orphan Indication Chronic lymphocytic leukemia
USA Market Approval USA
USA Designation Date 2005-08-12 00:00:00
Sponsor Novartis Pharmaceutical Corporation;Oncology Business Unit, One Health Plaza, Bldg 104;East Hanover, New Jersey, 07936